Aurobindo Pharma gets USFDA nod for generic of Revatio drug

Aurobindo Pharma gets USFDA nod for generic of Revatio drug

The drug is used to treat pulmonary arterial hypertension and improve exercise capacity in adults

FPJ Web DeskUpdated: Thursday, December 29, 2022, 11:16 AM IST
article-image
Image credit: Wikipedia (Representative)

Aurobindo Pharma Ltd has received USFDA (US Food and Drug Administration) approval to market sildenafil citrate oral suspension in a 10 mg per mL strength, according to an update on the drug regulator's website.

The drug is a generic version of Viatris Inc's Revatio oral suspension.

It is used to treat pulmonary arterial hypertension and improve exercise capacity in adults.

RECENT STORIES

Silver Rallies To Hit Fresh Peak, Gold Gains ₹540 As Israel-Iran Conflict Intensifies

Silver Rallies To Hit Fresh Peak, Gold Gains ₹540 As Israel-Iran Conflict Intensifies

Sensex, Nifty Close Lower Amid Middle East Tensions; Investors Await US Fed Interest Rate Decision

Sensex, Nifty Close Lower Amid Middle East Tensions; Investors Await US Fed Interest Rate Decision

Apple College Offer 2025 Now Live: Free AirPods Pro 2, AirPods 4 With Select Mac and iPad Devices

Apple College Offer 2025 Now Live: Free AirPods Pro 2, AirPods 4 With Select Mac and iPad Devices

Dassault-Reliance To build Falcon Jets In India, Full Aircraft Assembly To Begin In Nagpur From 2025

Dassault-Reliance To build Falcon Jets In India, Full Aircraft Assembly To Begin In Nagpur From 2025

Starlink Joins Hands With Reliance Jio & Airtel: "To Power Digital India's Soaring Ambitions," Says...

Starlink Joins Hands With Reliance Jio & Airtel: